Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A novel mechanism-based pharmacokinetic-pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteria.

Kristoffersson AN, Bissantz C, Okujava R, Haldimann A, Walter I, Shi T, Zampaloni C, Nielsen EI.

J Antimicrob Chemother. 2019 Oct 31. pii: dkz440. doi: 10.1093/jac/dkz440. [Epub ahead of print]

PMID:
31670804
2.

Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.

Barnes MD, Taracila MA, Good CE, Bajaksouzian S, Rojas LJ, van Duin D, Kreiswirth BN, Jacobs MR, Haldimann A, Papp-Wallace KM, Bonomo RA.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00432-19. doi: 10.1128/AAC.00432-19. Print 2019 Aug.

PMID:
31182530
3.

Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae.

Mushtaq S, Vickers A, Woodford N, Haldimann A, Livermore DM.

J Antimicrob Chemother. 2019 Apr 1;74(4):953-960. doi: 10.1093/jac/dky522.

PMID:
30590470
4.

Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.

Entenza JM, Haldimann A, Giddey M, Lociuro S, Hawser S, Moreillon P.

Antimicrob Agents Chemother. 2009 Sep;53(9):3635-41. doi: 10.1128/AAC.00325-09. Epub 2009 Jun 29.

5.

Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.

Oefner C, Bandera M, Haldimann A, Laue H, Schulz H, Mukhija S, Parisi S, Weiss L, Lociuro S, Dale GE.

J Antimicrob Chemother. 2009 Apr;63(4):687-98. doi: 10.1093/jac/dkp024. Epub 2009 Feb 11.

PMID:
19211577
10.

Structure-based redesign of corepressor specificity of the Escherichia coli purine repressor by substitution of residue 190.

Lu F, Schumacher MA, Arvidson DN, Haldimann A, Wanner BL, Zalkin H, Brennan RG.

Biochemistry. 1998 Jan 27;37(4):971-82.

PMID:
9454587
12.

Altered recognition mutants of the response regulator PhoB: a new genetic strategy for studying protein-protein interactions.

Haldimann A, Prahalad MK, Fisher SL, Kim SK, Walsh CT, Wanner BL.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14361-6.

13.

Conditionally replicative and conjugative plasmids carrying lacZ alpha for cloning, mutagenesis, and allele replacement in bacteria.

Metcalf WW, Jiang W, Daniels LL, Kim SK, Haldimann A, Wanner BL.

Plasmid. 1996 Jan;35(1):1-13.

PMID:
8693022
14.

Immune response against the L-lactate dehydrogenase of Mycoplasma hyopneumoniae in enzootic pneumonia of swine.

Frey J, Haldimann A, Kobisch M, Nicolet J.

Microb Pathog. 1994 Nov;17(5):313-22.

PMID:
7723658
15.

Sequence analysis and transcription of the apxI operon (hemolysin I) from Actinobacillus pleuropneumoniae.

Frey J, Haldimann A, Nicolet J, Boffini A, Prentki P.

Gene. 1994 May 3;142(1):97-102.

PMID:
8181764
16.
17.

Chromosomal heterogeneity of various Mycoplasma hyopneumoniae field strains.

Frey J, Haldimann A, Nicolet J.

Int J Syst Bacteriol. 1992 Apr;42(2):275-80.

PMID:
1316139
18.

Use of antibodies against the P36 protein of Mycoplasma hyopneumoniae for the identification of M. hyopneumoniae strains.

Stipkovits L, Nicolet J, Haldimann A, Frey J.

Mol Cell Probes. 1991 Dec;5(6):451-7.

PMID:
1723490

Supplemental Content

Loading ...
Support Center